Pharmaceutical CEOs are among the most widely traveled executives in the corporate world. Their work takes them from Washington, D.C. for FDA advisory committee meetings to Basel for EMA regulatory reviews, from Tokyo for partner negotiations to London for investor roadshows, and from San Diego for biotech conferences to Geneva for World Health Organization engagements. Managing this travel with the precision and flexibility that the role demands is one of the most critical responsibilities of the CEO’s personal assistant.
The Complexity of Pharma CEO Travel
Travel management for a pharmaceutical CEO is fundamentally different from booking corporate travel for a typical business executive. Several factors contribute to this complexity.
First, the itineraries are rarely static. A CEO’s schedule may be set weeks in advance, but regulatory developments, clinical trial data readouts, or acquisition opportunities can require schedule changes with little notice. The PA must be able to pivot quickly, rebooking flights and hotels while minimizing disruption to other commitments.
Second, many destinations require specialized logistics. Travel to regulatory agency headquarters often involves coordinating with government relations staff who manage meeting protocols. International travel to countries with strict visa requirements for pharmaceutical executives or with data privacy laws affecting document transport requires advance planning.
Third, the stakes of missed or delayed travel are high. A CEO who arrives late to an FDA pre-NDA meeting or misses the first hour of an investor roadshow has created a problem that cannot be fully recovered. The PA’s job is to build travel plans that have sufficient buffer and contingency to absorb the inevitable disruptions of air travel.
Building the Pharma Travel Calendar
The PA begins travel planning by building a master travel calendar that maps the CEO’s likely destinations against the annual calendar of external commitments. This includes:
- Fixed regulatory milestones, such as FDA advisory committee meetings, PDUFA dates, and EMA committee meetings
- Recurring investor events, including earnings calls, non-deal roadshows, and major investor conferences such as JPMorgan Healthcare Conference and Goldman Sachs Global Healthcare Conference
- Industry conferences, including BIO International Convention, ASH, ASCO, ESMO, and therapeutic area-specific meetings
- Board meeting dates, which may require travel to headquarters or board retreat locations
- Partner and licensing meetings with other pharmaceutical companies, which may occur at any location
By mapping these events against each other, the PA can identify potential conflicts early and work with the CEO to prioritize or resolve them.
Private Aviation and Commercial Travel
Many pharmaceutical CEOs at larger companies travel primarily by private aircraft, at least for domestic legs. The PA who manages private aviation must be comfortable working with flight departments or charter brokers, understanding the logistics of FBO (fixed-base operator) facilities, managing repositioning of aircraft, and coordinating ground transportation at both ends of each leg.
For international travel, even executives with access to private aviation often use commercial carriers for transcontinental routes where commercial options are more practical. The PA manages premium cabin bookings, lounge access, and the scheduling of arrival to provide adequate rest before important meetings.
For CEOs at smaller pharmaceutical companies who travel exclusively commercially, the PA masters the art of routing and scheduling to maximize efficiency, such as identifying the best connecting airports for European travel from the U.S. East Coast, or positioning the CEO within an airport between back-to-back meetings in the same city.
Documentation and International Travel Requirements
International pharmaceutical travel brings documentation requirements beyond a valid passport. Depending on destination and purpose of travel, these may include:
- Visa applications, some of which require significant lead time and may require the CEO’s passport for a period
- Import and export permits for materials being transported
- Letters of invitation from host organizations
- Proof of pharmaceutical company affiliation for regulatory meetings
- Travel authorizations from the company’s legal or compliance team for countries with heightened anti-corruption risk
The PA maintains a tracking system for the CEO’s travel documents, including passport expiration dates, existing visa validity, and trusted traveler program memberships such as Global Entry and TSA PreCheck. Passport renewal and visa applications are initiated well in advance of need, not when a trip is imminent.
Ground Transportation and Security
In many cities and countries visited by pharmaceutical CEOs, security arrangements are a component of travel planning. For executives traveling to markets where corporate security protocols apply, the PA coordinates with the company’s security team to arrange appropriate ground transportation, lodging with suitable security profiles, and emergency contact protocols.
For routine travel, the PA builds reliable relationships with car service providers in frequently visited cities. A trusted driver who knows how to navigate New York City traffic to reach Penn Station for an Amtrak departure, or who can get the CEO from CDG to a meeting in Paris’s 8th arrondissement during morning rush, is worth maintaining year after year.
Hotel selection is not merely about amenity preferences. The PA selects properties based on proximity to meeting locations, availability of appropriate meeting space if the CEO needs to conduct calls from the hotel, security profile, and the CEO’s documented preferences for room type, floor level, and check-in logistics.
Managing International Time Zones and Jet Lag
Pharmaceutical executives who travel internationally face the cumulative cognitive burden of jet lag, a real performance issue when the CEO needs to be sharp for an FDA meeting in Rockville after a red-eye from London. The experienced PA thinks carefully about scheduling in a way that gives the CEO recovery time when possible.
This means building pre-travel recovery time into itineraries, choosing flight routings that arrive at the optimal local time, and scheduling demanding meetings at times of day when the CEO’s cognitive performance will be best despite time zone adjustment. The PA who understands circadian biology and the CEO’s personal patterns around jet lag recovery provides genuine value beyond logistics.
The PA also manages the CEO’s communication schedule during travel to ensure that time zone differences do not result in 3 a.m. calls or missed commitments with teams in other locations.
Coordinating Multi-City Roadshow Logistics
Investor roadshows are among the most logistically intensive travel programs the PA will manage. A typical pharmaceutical company roadshow may cover New York, Boston, San Francisco, and London over five business days, with the CEO conducting six to ten investor meetings per day.
The PA works with the investment banks and the internal IR team to build an itinerary that makes geographic sense, uses time efficiently between meetings, and incorporates appropriate meal and rest time. Ground transportation between meeting locations must be timed precisely, accounting for traffic patterns and the variable length of investor meetings.
The PA prepares a detailed briefing book for each roadshow, including the schedule, meeting locations, investor names and fund information, driver contact numbers, hotel confirmation details, and any relevant background on investor priorities. This briefing book is the CEO’s operational guide for a week that will offer little time for improvisation.
Emergency Travel Planning
In pharmaceutical companies, emergencies arise that require the CEO to travel with minimal notice. A serious adverse event in a clinical trial, a critical regulatory development, or an acquisition opportunity requiring a face-to-face meeting may all require the CEO to be on a plane within hours.
The PA maintains standing relationships with travel providers who can respond to emergency booking requests, keeps the CEO’s travel documents organized and accessible, and maintains a personal go-bag checklist that allows rapid departure. For executives with access to private aviation, the PA maintains relationships with charter brokers who can source last-minute aircraft when the company’s own aircraft is not available.
The ability to manage emergency travel calmly and effectively is a defining characteristic of the most capable executive PAs in the pharmaceutical industry. It requires advance preparation, reliable vendor relationships, and the composure to function well under pressure.
For more context on the PA’s full range of responsibilities in pharma, see our detailed breakdown of pharma PA duties. To understand how these travel responsibilities fit within the broader PA role at pharma and biotech companies, visit our guide to the pharma CEO assistant.
Conclusion
Managing global travel for a pharmaceutical CEO is a discipline that combines logistics expertise, relationship management, regulatory awareness, and contingency planning. PAs who do this work at a high level are genuine strategic assets, enabling their CEOs to engage effectively with the full global landscape of regulatory, investor, and partner relationships that determine the company’s success.
Related Reading
For further context, explore Personal Assistant for 3PL CEO Third Party Logistics: Operational Support for a High-Volume Industry and Personal Assistant for Abrasive Manufacturer CEO.